NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

NCT00053989 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Diseases
Fanconi Anemia
Aplastic Anemia

Interventions

BIOLOGICAL: anti-thymocyte globulin
BIOLOGICAL: graft-versus-tumor induction therapy
BIOLOGICAL: sargramostim
BIOLOGICAL: therapeutic allogeneic lymphocytes
DRUG: cyclophosphamide
DRUG: fludarabine phosphate
DRUG: methylprednisolone
DRUG: mycophenolate mofetil
DRUG: tacrolimus
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: peripheral blood stem cell transplantation
PROCEDURE: umbilical cord blood transplantation

Sponsor

Roswell Park Cancer Institute